The major news about Medtronic Plc (MDT) revolves around its robust performance in the financial market and in dividend growth. Medtronic, a leading medical device company, declared a cash dividend for Q4 2025 and has shown promise in its earnings. The company maintains a 47-year dividend growth streak and is recognized by billionaires as a top dividend stock. Despite a minor dip in Q3 revenue, Medtronic displays strong financial results for Q2 and Q3 of fiscal 2025, driven by significant growth in Cardiac, surgical revenue, and neuroscience sectors. Medtronic's stock trades cheaper than its peers, presenting an investment opportunity. Advancements in AI-driven healthcare, study data, and innovations transforming spine surgery and medical therapies highlight its technological advancements. The appointments and departure of executive members also caught attention. The company gained FDA approval for its deep brain stimulation system for Parkinson's, reinforcing its innovative capabilities. Notably, the stocks performed slightly below market expectations but still recorded significant price target raises.
Medtronic Plc MDT News Analytics from Thu, 09 May 2024 07:00:00 GMT to Fri, 07 Mar 2025 22:07:39 GMT - Rating 7 - Innovation 8 - Information 7 - Rumor 5
